DURECT Corp (DRRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts DRRX Hot Sheet
Price: $1.91 --0%
Financial Fact:
Selling, general and administrative: 3.04M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Selling, general and administrative: 3.04M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
DURECT Corp (NASDAQ: DRRX) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.77 million.
For earnings history and earnings-related data on DURECT Corp (DRRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
